❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive

Digital Public Defence Apr. 26, 2021 12:15 Maxi-Lu Böschen

Maxi-Lu Böschen
Maxi-Lu Böschen

MSc Maxi-Lu Böschen from the Experimental Immunotherapy Group headed by Johanna Olweus will be defending her thesis Towards new T cell receptor-based cancer immunotherapy for the degree of PhD (Philosophiae Doctor).

Time and place: Apr. 26, 2021 12:15 PM, Zoom
 

Links:

Read complete announcement from UiO home page

Maxi-Lu Böschen

The Experimental Immunotherapy Group, headed by Johanna Olweus

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Miihkinen M, Chu Y, Vakkilainen S, Akimov Y, Aittokallio T (2026)
Estimating the completeness of large-scale single-cell sequencing projects
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-78221-5, PubMed 42982821

Serguienko A, Sharma J, Shakya R, Cheng Munthe-Kaas M, Boye K, Myklebost O (2026)
Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer
Front Immunol, 17, 1911932
DOI 10.3389/fimmu.2026.1911932, PubMed 42953060

Pinto R, Sjurgard IV, Hauge T, Brandt-Winge S, Pharo H, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Kumar T, Øvrebø KK, Rekstad LC, Aahlin EK, Johnson E, Mala T, Lind GE (2026)
DNA methylation-based immune profiling reveals distinct subtypes in esophageal adenocarcinoma
Eur J Cancer, 249, 117076 (in press)
DOI 10.1016/j.ejca.2026.117076, PubMed 42950611

More selected publications

Most recent publications

Duléry R, Malmberg KJ, Romee R (2026)
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular Therapy
Blood Cancer Discov, 7 (6), 856-859
DOI 10.1158/2643-3230.BCD-26-0086, PubMed 41996826

Lecaudey LA, Ghasemishahrestani Z, Saqagandomabadi V, Wesche J, Ahi EP (2026)
Post-transcriptional regulation of FGF signaling: insights from musculoskeletal system
J Mol Biol, 170087 (in press)
DOI 10.1016/j.jmb.2026.170087, PubMed 42976986

Pinto R, Sjurgard IV, Hauge T, Brandt-Winge S, Pharo H, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Kumar T, Øvrebø KK, Rekstad LC, Aahlin EK, Johnson E, Mala T, Lind GE (2026)
DNA methylation-based immune profiling reveals distinct subtypes in esophageal adenocarcinoma
Eur J Cancer, 249, 117076 (in press)
DOI 10.1016/j.ejca.2026.117076, PubMed 42950611

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)